NL7017210A - - Google Patents

Info

Publication number
NL7017210A
NL7017210A NL7017210A NL7017210A NL7017210A NL 7017210 A NL7017210 A NL 7017210A NL 7017210 A NL7017210 A NL 7017210A NL 7017210 A NL7017210 A NL 7017210A NL 7017210 A NL7017210 A NL 7017210A
Authority
NL
Netherlands
Application number
NL7017210A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691959403 external-priority patent/DE1959403A1/de
Priority claimed from DE19702050815 external-priority patent/DE2050815A1/de
Priority claimed from DE19702050816 external-priority patent/DE2050816A1/de
Priority claimed from DE19702050814 external-priority patent/DE2050814A1/de
Application filed filed Critical
Publication of NL7017210A publication Critical patent/NL7017210A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL7017210A 1969-11-26 1970-11-25 NL7017210A (enExample)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19691959403 DE1959403A1 (de) 1969-11-26 1969-11-26 Neue 2-(5-Nitro-2-furyl)-thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
DE19702050815 DE2050815A1 (de) 1970-10-16 1970-10-16 Neue 2-(5-Nitro-2-furyl)-thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidine
DE19702050816 DE2050816A1 (de) 1970-10-16 1970-10-16 Neue 2-(Nitro-2-furyl>thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidine
DE19702050814 DE2050814A1 (de) 1970-10-16 1970-10-16 Neue Verfahren zur Herstellung von 2-(5-Nitro-2-furyl)-thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidinen

Publications (1)

Publication Number Publication Date
NL7017210A true NL7017210A (enExample) 1971-05-28

Family

ID=27430978

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7017210A NL7017210A (enExample) 1969-11-26 1970-11-25

Country Status (13)

Country Link
US (1) US3661908A (enExample)
BE (1) BE759493A (enExample)
BG (2) BG17800A3 (enExample)
CA (1) CA926865A (enExample)
CH (3) CH559210A5 (enExample)
DK (1) DK128781B (enExample)
FR (1) FR2073416B1 (enExample)
GB (1) GB1321316A (enExample)
IE (1) IE34765B1 (enExample)
IL (1) IL35729A (enExample)
NL (1) NL7017210A (enExample)
NO (1) NO129954B (enExample)
SE (1) SE377938B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932642A (en) * 1971-04-10 1976-01-13 Boehringer Ingelheim Gmbh Biocidal compositions containing a 2- (5'-nitro-2'-furyl)-thieno(2,3-d) pyrimidine and methods of use
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US20040138238A1 (en) * 2002-08-08 2004-07-15 Dhanoa Dale S. Substituted aminopyrimidine compounds as neurokinin antagonists
GB0423653D0 (en) * 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
CA2650295C (en) * 2006-04-26 2015-12-29 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
BRPI0710943A2 (pt) * 2006-04-26 2012-06-26 Genentech Inc compostos farmacêuticos
ES2347187T3 (es) * 2006-04-26 2010-10-26 F. Hoffmann-La Roche Ag Derivado de tieno(3,2-d)pirimidina, util como un inhibidor de pi3k.
US7888352B2 (en) 2006-12-07 2011-02-15 Piramed Limited Phosphoinositide 3-kinase inhibitor compounds and methods of use
AU2007333243B2 (en) * 2006-12-07 2013-03-14 F. Hoffmann-La Roche Ag Phosphoinositide 3-kinase inhibitor compounds and methods of use
US7893060B2 (en) * 2007-06-12 2011-02-22 F. Hoffmann-La Roche Ag Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
WO2009042607A1 (en) * 2007-09-24 2009-04-02 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
CN101909631B (zh) 2007-10-25 2012-09-12 健泰科生物技术公司 制备噻吩并嘧啶化合物的方法
GB0721095D0 (en) * 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
CA2753285A1 (en) 2009-03-12 2010-09-16 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
JP5781066B2 (ja) 2009-05-27 2015-09-16 ジェネンテック, インコーポレイテッド p110δに対して選択的な二環式ピリミジンPI3K阻害剤化合物及び使用方法
CA2772371A1 (en) * 2009-05-27 2010-12-02 F. Hoffmann-La Roche Ag Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
TWI428336B (zh) * 2009-10-12 2014-03-01 Hoffmann La Roche Pi3k抑制劑及mek抑制劑之組合
KR20130058672A (ko) 2010-04-16 2013-06-04 제넨테크, 인크. PI3K/AKT 키나제 경로 억제제 효능에 대한 예측 바이오마커로서의 FOXO3a
US20140004209A1 (en) 2010-12-22 2014-01-02 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
MX369175B (es) 2013-02-25 2019-10-30 Genentech Inc Métodos para detectar mutantes de akt resistentes a fármacos.

Also Published As

Publication number Publication date
SE377938B (enExample) 1975-08-04
FR2073416B1 (enExample) 1975-04-18
CH559210A5 (enExample) 1975-02-28
IE34765B1 (en) 1975-08-06
NO129954B (enExample) 1974-06-17
CH567029A5 (enExample) 1975-09-30
IL35729A0 (en) 1971-01-28
GB1321316A (en) 1973-06-27
CH568324A5 (enExample) 1975-10-31
BG17799A3 (bg) 1973-12-25
BE759493A (fr) 1971-05-25
IE34765L (en) 1971-05-26
FR2073416A1 (enExample) 1971-10-01
US3661908A (en) 1972-05-09
BG17800A3 (bg) 1973-12-25
IL35729A (en) 1974-01-14
CA926865A (en) 1973-05-22
DK128781B (da) 1974-07-01

Similar Documents

Publication Publication Date Title
FR2073416B1 (enExample)
AU465413B2 (enExample)
AU4221168A (enExample)
AU450150B2 (enExample)
AU442375B2 (enExample)
AU470301B1 (enExample)
AU427401B2 (enExample)
AU425297B2 (enExample)
AU442357B2 (enExample)
AU442380B2 (enExample)
AU442554B2 (enExample)
AU442463B2 (enExample)
AU470661B1 (enExample)
AU442535B2 (enExample)
CS149994B1 (enExample)
AU6077869A (enExample)
CS149291B1 (enExample)
AU4540468A (enExample)
AU5988769A (enExample)
AU5979569A (enExample)
CS150090B1 (enExample)
AU5397469A (enExample)
AU5228269A (enExample)
AU5109569A (enExample)
AU5077469A (enExample)